Yu-Wai-Man Patrick, Griffiths Philip G
Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Cochrane Database Syst Rev. 2013 Jun 18;6(6):CD005024. doi: 10.1002/14651858.CD005024.pub3.
Traumatic optic neuropathy (TON) is an important cause of severe visual loss following blunt or penetrating head trauma. Following the initial insult optic nerve swelling within the optic nerve canal or compression by bone fragments are thought to result in secondary retinal ganglion cell loss. Optic nerve decompression with steroids or surgical interventions or both have therefore been advocated to improve visual prognosis in TON.
To examine the effects and safety of surgical interventions in the management of TON.
We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2013, Issue 4), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE, (January 1950 to May 2013), EMBASE (January 1980 to May 2013), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to May 2013), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (http://clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 28 May 2013. We also searched the reference lists of other reviews and book chapters on TON. We also contacted researchers in the field.
We planned to include only randomised controlled trials (RCTs) of TON in which any form of surgical intervention either on its own or in combination with steroids was compared to steroids alone or no treatment.
Two authors independently assessed the titles and abstracts identified from the search strategy. No studies were found that met our inclusion criteria and therefore none were included for analysis.
No studies were found that met our inclusion criteria.
AUTHORS' CONCLUSIONS: The current body of evidence consists mostly of small, retrospective case series. Given the wide range of surgical interventions used in TON it is very difficult to compare these studies, even qualitatively. However, there is a relatively high rate of spontaneous visual recovery and no evidence that surgical decompression of the optic nerve provides any additional benefit. On the other hand, surgery carries a definite risk of complications such as postoperative cerebrospinal fluid leak and meningitis. The decision to proceed with surgery in TON therefore remains controversial and each case needs to be assessed on its own merits. Although there is an urgent need for an adequately powered, RCT of surgical intervention in TON, this will prove a difficult endeavour.
创伤性视神经病变(TON)是钝性或穿透性头部外伤后严重视力丧失的重要原因。在初始损伤后,视神经管内的视神经肿胀或骨碎片压迫被认为会导致继发性视网膜神经节细胞丢失。因此,有人主张使用类固醇或手术干预或两者结合进行视神经减压,以改善TON的视力预后。
研究手术干预在TON治疗中的效果和安全性。
我们检索了Cochrane系统评价数据库(CENTRAL,其中包含Cochrane眼科和视力组试验注册库)(《Cochrane图书馆》2013年第4期)、Ovid MEDLINE、Ovid MEDLINE在研及其他未索引引文、Ovid MEDLINE每日更新、Ovid OLDMEDLINE(1950年1月至2013年5月)、EMBASE(1980年1月至2013年5月)、拉丁美洲和加勒比地区卫生科学文献数据库(LILACS)(1982年1月至2013年5月)、对照试验元注册库(mRCT)(www.controlled-trials.com)、ClinicalTrials.gov(http://clinicaltrials.gov)以及世界卫生组织国际临床试验注册平台(ICTRP)(www.who.int/ictrp/search/en)。在电子检索试验时,我们未使用任何日期或语言限制。我们最后一次检索电子数据库的时间是2013年5月28日。我们还检索了关于TON的其他综述和书籍章节的参考文献列表。我们还联系了该领域的研究人员。
我们计划仅纳入TON的随机对照试验(RCT),其中将任何形式的手术干预单独或与类固醇联合使用与单独使用类固醇或不治疗进行比较。
两位作者独立评估了从检索策略中识别出的标题和摘要。未发现符合我们纳入标准的研究,因此没有纳入分析的研究。
未发现符合我们纳入标准的研究。
目前的证据大多由小型回顾性病例系列组成。鉴于TON中使用的手术干预范围广泛,即使进行定性比较这些研究也非常困难。然而,自发视力恢复率相对较高,且没有证据表明视神经手术减压能带来任何额外益处。另一方面,手术存在明确的并发症风险,如术后脑脊液漏和脑膜炎。因此,TON是否进行手术的决定仍存在争议,每个病例需要根据其自身情况进行评估。尽管迫切需要进行一项关于TON手术干预的有足够样本量的RCT,但这将是一项艰巨的任务。